CONSTANT LEVERAGE LONG - FAGRON Share Price

EU5FB

NLBNPNL1S5S9

Market Closed - Euronext Paris 17:30:01 03/05/2024 BST
6.225 ^EUR	-0.16%

Current month	-0.08%
1 month	+16.75%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart FAGRON N.V.

Latest news about FAGRON N.V.

Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting	04-15	AQ
Fagron N : NV, - publiceert agenda jaarlijkse en buitengewone aandeelhoudersvergadering 2024	04-12	PU
Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting	04-12	GL
Transcript : Fagron NV, Q1 2024 Sales/ Trading Statement Call, Apr 11, 2024	04-11

More news

Quotes 5-day view

Date	Price	Change	Volume
03/05/24	6.225	-0.16%	36
02/05/24	6.235	+0.40%	45
30/04/24	6.21	+1.55%	42
29/04/24	6.115	+6.35%	49
26/04/24	5.75	+2.31%	40

Real-time Euronext Paris

Last update May 03, 2024 at 05:30 pm

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	FAGRON N.V.
Issuer	BNP Paribas
	EU5FB
ISIN	NLBNPNL1S5S9
Date issued	11/04/2022
Maturity	Unlimited
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	12.07 €
Lowest since issue	2.05 €
Spread	0.29 €
Spread %	4.55%

Company Profile

Fagron N.V. specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The group ensures the sale of pharmaceutical formulas and raw materials, provides third-party pharmaceutical compounding services to pharmacists and hospitals, etc.

Sector

More about the company

Ratings for Fagron N.V.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Fagron N.V.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

18.24 EUR

Average target price

21.7 EUR

Spread / Average Target

+18.97%

Consensus